Please provide your email address to receive an email when new articles are posted on . Robotic-assisted cystectomy demonstrated comparable 2-year PFS to open cystectomy among patients with bladder ...

In a randomized study, patients who underwent robotic-assisted and open radical cystectomy had similar 2-year progression survival rates. Robot-assisted radical cystectomy (RC) for invasive bladder ...

Use of robot-assisted vs. open radical cystectomy led to a significantly increased number of days alive and out of the hospital among patients with nonmetastatic bladder cancer. Perspective from David ...

Robotic surgery for bladder cancer speeds recovery, reduces pain, and improves quality of life. It also significantly reduces risks such as blood clots and can preserve functions like sexual health.

Robot-assisted radical cystectomy with intracorporeal urinary diversion vs open radical cystectomy resulted in a median of 82 vs 80 days alive and out of the hospital within 90 days of surgery. While ...

Extended oral antibiotic prophylaxis eliminated UTIs after robot-assisted radical cystectomy procedures. Prophylactic antibiotics reduced overall infections by two-thirds and saved $9,000 per patient.

How does robot-assisted radical cystectomy compare with traditional open radical cystectomy for management of patients with bladder cancer? To answer this question, the authors of a study published in ...

Patients whose cancerous bladder was removed using a surgical robot experienced fewer postoperative complications than those who underwent open cystectomy, report Douglas Scherr and colleagues.

Robot-assisted and open radical cystectomy are associated with similar 90-day complication rates, health-related quality of life, and clinical outcomes, according to a recent real-world study.

This transcript has been edited for clarity. Cheryl Lee, MD: Welcome to Medscape InDiscussion. I'm Cheryl Lee, and today we'll be discussing a topic that has continued to be controversial. I'm ...

Impact of concurrent angiotensin inhibitors on outcomes with PD1/L1 inhibitors for patients (pts) with metastatic urothelial carcinoma (mUC). This is an ASCO Meeting Abstract from the 2020 ASCO Annual ...

A randomized controlled trial has shown that short-term outcomes following robot-assisted radical cystectomy compare favorably with those of open surgery. To date, a lack of hard clinical evidence to ...